Related Experiment Video
Updated: May 6, 2026
10:33
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
4.3K
The future of uveitis treatment
Phoebe Lin1, Eric B Suhler2, James T Rosenbaum3
1Casey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Ophthalmology
|October 31, 2013
Summary
Uveitis treatments face challenges due to disease complexity. Future breakthroughs in uveitis therapy will likely stem from mechanism-based approaches targeting immune regulation and novel drug delivery systems.
Area of Science:
- Ophthalmology
- Immunology
- Pharmacology
Background:
- Uveitis is a complex eye inflammation with diverse causes, complicating clinical trials.
- Current treatments like corticosteroids and immunomodulators are effective but have side effects.
- Developing safer and more effective uveitis therapies is a critical unmet need.
Purpose of the Study:
- To review current understanding of immune dysregulation in uveitis.
- To explore novel therapeutic targets and drug delivery strategies for uveitis.
- To highlight mechanism-based approaches for future uveitis treatment breakthroughs.
Main Methods:
- Literature review of immune regulation and dysregulation in uveitis.
- Analysis of existing and emerging therapeutic strategies.
- Discussion of novel drug delivery platforms for ocular inflammation.
Main Results:
- Targeting inflammatory cytokines, T-lymphocyte activation, and intracellular pathways shows therapeutic potential.
- Small molecule inhibitors offer orally bioavailable treatment options.
- Emerging strategies include lipid mediators, recombinant proteins, gene therapy, and advanced drug delivery systems.
Conclusions:
- A mechanism-based approach is key to advancing uveitis treatment.
- Novel therapies targeting specific immune pathways and utilizing advanced delivery methods promise improved efficacy and safety.
- Continued research into uveitis pathogenesis will drive the development of next-generation treatments.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
721
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
721
01:26Nephrotic Syndrome II : Assessment and Medical Management
424
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
424
01:25Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
01:14Myocarditis III: Medical Management
346
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
346